Moderna CEO : May Announce the Results of the New Coronavirus Vaccine Research in October

'The Wall Street Journal' reported on September 18 that the person-in-charge of Moderna said that a large key study on the company's new coronavirus vaccine may have a preliminary answer as early as October, but it is more likely to be in November.

Moderna CEO Stephane Bancel said in an interview that the exact time will depend on the infection rate in the US region where the trial is conducted, because this study is to compare whether vaccinated people have fewer new coronary symptoms than people who have not been vaccinated.